Therapeutic Drug Monitoring as a Useful Tool in Therapy Improvement, 3rd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".
Deadline for manuscript submissions: 30 November 2025
Special Issue Editors
Interests: drug analysis; pharmacokinetics; aritficial neural networks; data mining; drug–drug interactions
Special Issues, Collections and Topics in MDPI journals
Interests: therapeutic drug monitoring; HPLC; method validation; polymorphism; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: therapeutic drug monitoring; pediatrics; analytical methods; population pharmacokinetics; drug–drug interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Responses to therapy may vary between patients. Therapeutic drug monitoring is helpful for addressing this phenomenon. This Special Issue is targeted towards authors whose work focuses on therapeutic drug monitoring. We invite submissions concerning observed drug–drug interactions based on the effects of drug concentrations on biological matrices, as well as their pharmacokinetic impacts. Original papers concerning new drugs for which therapeutic drug monitoring may be beneficial are also welcome, as are those focused on new approaches for therapeutic drug monitoring. Interactions in the pharmacokinetic phase may also be observed in animal models; however, they must be relevant to the human body. In this context, papers concerning pharmacokinetic interactions in both human and animal models are welcome. We also encourage manuscripts in which machine learning techniques are applied in TDM or in the evaluation of side effects of pharmacotherapy. This Special Issue will include original and review articles.
Dr. Andrzej Czyrski
Dr. Matylda Resztak
Dr. Joanna Sobiak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug–drug interactions
- pharmacokinetics
- therapeutic drug monitoring
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
